文献速递肝病消化道肿瘤与早癌

剪接调节因子p54nrb/NONO通过BIN1致癌异构体转换促进肝细胞癌发生

Splicing Regulator p54nrb /Non-POU Domain-Containing Octamer-Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box-Dependent Interacting Protein 1 in Hepatocellular Carcinoma.
PubMed 文献 · Hepatology · 2020-03-25

肝细胞癌中RNA结合蛋白NONO表达常升高且与不良预后相关。NONO与DHX9、SFPQ形成复合物,促进BIN1外显子12a纳入,使抑癌性BIN1-S转换为致癌性BIN1-L;BIN1-L结合PLK1并阻止其经泛素/蛋白酶体依赖的Cullin 3降解,从而增强PLK1稳定性促进癌变。

要点

  • HCC中NONO高表达与不良预后相关,敲低NONO可抑制肝癌细胞增殖、迁移和成瘤。
  • NONO通过DHX9-NONO-SFPQ复合物促进BIN1外显子12a纳入,使BIN1-S转换为BIN1-L。
  • BIN1-L结合PLK1并阻止Cullin 3介导的泛素/蛋白酶体降解,增强PLK1稳定性促癌。

核心结论

  • DHX9-NONO-SFPQ复合物是调控BIN1致癌剪接转换的关键因子,并可能成为肝癌治疗候选靶点。

研究设计与样本

  • 研究基于HCC患者样本与肝癌细胞模型,采用敲低、RNA测序及机制实验分析NONO与BIN1剪接调控。

主要发现

  • HCC患者中NONO表达常升高并与不良结局相关。
  • 敲低NONO显著抑制肝癌细胞增殖、迁移和肿瘤形成。
  • RNA测序显示NONO调控BIN1外显子12a剪接。
  • 正常肝脏中BIN1产生抑癌性短异构体BIN1-S,抑制c-Myc与靶基因启动子结合。
  • HCC中NONO高表达产生含外显子12a的长异构体BIN1-L,促进癌变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Alternative splicing (AS) is a key step that increases the diversity and complexity of the cancer transcriptome. Recent evidence has highlighted that AS has an increasingly crucial role in cancer. Nonetheless, the mechanisms underlying AS and its dysregulation in hepatocellular carcinoma (HCC) remain elusive. Here, we report that the expression of RNA-binding protein p54nrb /non-POU domain-containing octamer-binding protein (NONO) is frequently increased in patients with HCC and is associated with poor outcomes. APPROACH AND RESULTS: Knockdown of NONO significantly abolished liver cancer cell proliferation, migration, and tumor formation. RNA-sequencing revealed that NONO regulates MYC box-dependent interacting protein 1 (or bridging integrator 1 [BIN1]; also known as amphiphysin 2 3P9) exon 12a splicing. In the normal liver, BIN1 generates a short isoform (BIN1-S) that acts as a tumor suppressor by inhibiting the binding of c-Myc to target gene promoters. In HCC, NONO is highly up-regulated and produces a long isoform (BIN1-L, which contains exon 12a) instead of BIN1-S. High levels of BIN1-L promote carcinogenesis by binding with the protein polo-like kinase 1 to enhance its stability through the prevention of ubiquitin/proteasome-dependent cullin 3 degradation. Further analysis revealed that NONO promotes BIN1 exon 12a inclusion through interaction with DExH-box helicase 9 (DHX9) and splicing factor proline and glutamine-rich (SFPQ). Notably, frequent coexpression of DHX9-NONO-SFPQ is observed in patients with HCC. CONCLUSIONS: Taken together, our findings identify the DHX9-NONO-SFPQ complex as a key regulator manipulating the oncogenic splicing switch of BIN1 and as a candidate therapeutic target in liver cancer.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Hu Z, Dong L, Li S, et al. Splicing Regulator p54nrb /Non-POU Domain-Containing Octamer-Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box-Dependent Interacting Protein 1 in Hepatocellular Carcinoma. Hepatology. 2020. PMID: 31815296. doi:10.1002/hep.31062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。